碱性磷酸酶在危重病人中的应用

Zohra R Malik
{"title":"碱性磷酸酶在危重病人中的应用","authors":"Zohra R Malik","doi":"10.47363/pms/2021(5)153","DOIUrl":null,"url":null,"abstract":"Most of the patients admitted to ICU undergo organ damage, with kidney injury, liver damage, respiratory distress and hematological derangements being the most common. We hereby present literature review on the use of Alkaline Phosphatase (ALP) in critically ill patients with severe sepsis causing kidney injury. The possible cause of kidney injury is inflammation and hypoxia. ALP may prevent the effects of inflammation and hypoxia through dephosphorylation of lipopolysaccharide (LPS) and extracellular ATP, the latter being converted to adenosine, an anti-inflammatory and tissue-protective signaling molecule [1]. The anti-inflammatory effects of ALP on LPS-induced systemic inflammation is the proposed mechanism. ALP detoxifies LPS and the dephosphorylated LPS is far less toxic [2]. LPS can be dephosphorylated by ALP as shown by various experiments and this eventually improves survival [2-4]. ALP is proposed to reduce fever and attenuate the systemic cytokine response, serum nitric oxide levels, and prevent liver and lung damage [5, 6]. ALP is also shown through animal experiments to reduce TNF-a response, reduce IL-6 concentration, improve gas exchange during septic shock [4, 7]. An animal experiment was conducted, which showed if we give an ALP inhibitor (L-phenylalanine), the serum LPS levels significantly increase, causing the pathogenesis of septic shock. TLR (toll-like receptor), plays an important role in pathogen recognition and activation of the innate immunity. ALP seems to interact with the LPS-TLR pathway. The LPS induces an increase in NF-kB activity which seems to be attenuated in the cells that were pre-treated with ALP. The pro-inflammatory molecule, Resolvin-E1 reduces LPS induced NF-kB activity [8, 9]. which is mediated through de-phosphorylation and thereby detoxification of LPS. So, if we can attenuate the circulating LPS and cytokine levels by ALP, we can prevent renal hypoxia and AKI. Restoration of ALP might be an evident solution to preventing kidney and other organ injury","PeriodicalId":121507,"journal":{"name":"Progress in Medical Sciences","volume":"136 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Use of Alkaline Phosphatase in Critically-Ill Patients\",\"authors\":\"Zohra R Malik\",\"doi\":\"10.47363/pms/2021(5)153\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Most of the patients admitted to ICU undergo organ damage, with kidney injury, liver damage, respiratory distress and hematological derangements being the most common. We hereby present literature review on the use of Alkaline Phosphatase (ALP) in critically ill patients with severe sepsis causing kidney injury. The possible cause of kidney injury is inflammation and hypoxia. ALP may prevent the effects of inflammation and hypoxia through dephosphorylation of lipopolysaccharide (LPS) and extracellular ATP, the latter being converted to adenosine, an anti-inflammatory and tissue-protective signaling molecule [1]. The anti-inflammatory effects of ALP on LPS-induced systemic inflammation is the proposed mechanism. ALP detoxifies LPS and the dephosphorylated LPS is far less toxic [2]. LPS can be dephosphorylated by ALP as shown by various experiments and this eventually improves survival [2-4]. ALP is proposed to reduce fever and attenuate the systemic cytokine response, serum nitric oxide levels, and prevent liver and lung damage [5, 6]. ALP is also shown through animal experiments to reduce TNF-a response, reduce IL-6 concentration, improve gas exchange during septic shock [4, 7]. An animal experiment was conducted, which showed if we give an ALP inhibitor (L-phenylalanine), the serum LPS levels significantly increase, causing the pathogenesis of septic shock. TLR (toll-like receptor), plays an important role in pathogen recognition and activation of the innate immunity. ALP seems to interact with the LPS-TLR pathway. The LPS induces an increase in NF-kB activity which seems to be attenuated in the cells that were pre-treated with ALP. The pro-inflammatory molecule, Resolvin-E1 reduces LPS induced NF-kB activity [8, 9]. which is mediated through de-phosphorylation and thereby detoxification of LPS. So, if we can attenuate the circulating LPS and cytokine levels by ALP, we can prevent renal hypoxia and AKI. Restoration of ALP might be an evident solution to preventing kidney and other organ injury\",\"PeriodicalId\":121507,\"journal\":{\"name\":\"Progress in Medical Sciences\",\"volume\":\"136 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-06-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Progress in Medical Sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.47363/pms/2021(5)153\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Progress in Medical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47363/pms/2021(5)153","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

入住ICU的患者多发生器官损伤,以肾损伤、肝损伤、呼吸窘迫和血液学紊乱最为常见。我们在此对碱性磷酸酶(ALP)在严重脓毒症致肾损伤的危重患者中的应用进行文献综述。引起肾损伤的可能原因是炎症和缺氧。ALP可能通过脂多糖(LPS)和细胞外ATP的去磷酸化,后者转化为腺苷,一种抗炎和保护组织的信号分子来预防炎症和缺氧的影响[1]。ALP对脂多糖诱导的全身性炎症的抗炎作用是被提出的机制。ALP能解毒LPS,去磷酸化的LPS毒性小得多[2]。各种实验表明,LPS可以被ALP去磷酸化,最终提高生存率[2-4]。ALP被认为可以退烧,减弱全身细胞因子反应和血清一氧化氮水平,防止肝和肺损伤[5,6]。动物实验也显示ALP在脓毒性休克时可降低TNF-a反应,降低IL-6浓度,改善气体交换[4,7]。动物实验表明,给予ALP抑制剂(l -苯丙氨酸),血清LPS水平显著升高,引起感染性休克的发病机制。toll样受体(toll-like receptor, TLR)在病原体识别和先天免疫激活中起着重要作用。ALP似乎与LPS-TLR通路相互作用。LPS诱导NF-kB活性的增加,这种活性在ALP预处理的细胞中似乎减弱了。促炎分子Resolvin-E1降低LPS诱导的NF-kB活性[8,9]。这是通过去磷酸化介导的,从而使LPS解毒。因此,如果我们能通过ALP降低循环LPS和细胞因子水平,我们可以预防肾性缺氧和AKI。ALP的恢复可能是防止肾脏和其他器官损伤的明显解决方案
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Use of Alkaline Phosphatase in Critically-Ill Patients
Most of the patients admitted to ICU undergo organ damage, with kidney injury, liver damage, respiratory distress and hematological derangements being the most common. We hereby present literature review on the use of Alkaline Phosphatase (ALP) in critically ill patients with severe sepsis causing kidney injury. The possible cause of kidney injury is inflammation and hypoxia. ALP may prevent the effects of inflammation and hypoxia through dephosphorylation of lipopolysaccharide (LPS) and extracellular ATP, the latter being converted to adenosine, an anti-inflammatory and tissue-protective signaling molecule [1]. The anti-inflammatory effects of ALP on LPS-induced systemic inflammation is the proposed mechanism. ALP detoxifies LPS and the dephosphorylated LPS is far less toxic [2]. LPS can be dephosphorylated by ALP as shown by various experiments and this eventually improves survival [2-4]. ALP is proposed to reduce fever and attenuate the systemic cytokine response, serum nitric oxide levels, and prevent liver and lung damage [5, 6]. ALP is also shown through animal experiments to reduce TNF-a response, reduce IL-6 concentration, improve gas exchange during septic shock [4, 7]. An animal experiment was conducted, which showed if we give an ALP inhibitor (L-phenylalanine), the serum LPS levels significantly increase, causing the pathogenesis of septic shock. TLR (toll-like receptor), plays an important role in pathogen recognition and activation of the innate immunity. ALP seems to interact with the LPS-TLR pathway. The LPS induces an increase in NF-kB activity which seems to be attenuated in the cells that were pre-treated with ALP. The pro-inflammatory molecule, Resolvin-E1 reduces LPS induced NF-kB activity [8, 9]. which is mediated through de-phosphorylation and thereby detoxification of LPS. So, if we can attenuate the circulating LPS and cytokine levels by ALP, we can prevent renal hypoxia and AKI. Restoration of ALP might be an evident solution to preventing kidney and other organ injury
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信